Minoru Nakamura

7.2k total citations
130 papers, 3.9k citations indexed

About

Minoru Nakamura is a scholar working on Hepatology, Epidemiology and Immunology. According to data from OpenAlex, Minoru Nakamura has authored 130 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Hepatology, 59 papers in Epidemiology and 36 papers in Immunology. Recurrent topics in Minoru Nakamura's work include Liver Diseases and Immunity (58 papers), Liver Disease Diagnosis and Treatment (50 papers) and Systemic Lupus Erythematosus Research (17 papers). Minoru Nakamura is often cited by papers focused on Liver Diseases and Immunity (58 papers), Liver Disease Diagnosis and Treatment (50 papers) and Systemic Lupus Erythematosus Research (17 papers). Minoru Nakamura collaborates with scholars based in Japan, United States and United Kingdom. Minoru Nakamura's co-authors include Hiromi Ishibashi, Kiyoshi Migita, Atsumasa Komori, Shinji Shimoda, Paolo Casali, Abner Louis Notkins, Giorgio Inghirami, Hiroshi Yatsuhashi, Samuele E. Burastero and Yoshihiro Aiba and has published in prestigious journals such as Science, JAMA and The Journal of Immunology.

In The Last Decade

Minoru Nakamura

127 papers receiving 3.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Minoru Nakamura 1.5k 1.5k 1.2k 780 663 130 3.9k
William M. Ridgway 1.4k 1.0× 1.7k 1.1× 2.0k 1.6× 983 1.3× 566 0.9× 96 4.6k
K. H. Meyer zum Büschenfelde 1.9k 1.3× 1.9k 1.3× 2.1k 1.7× 1.2k 1.5× 1.4k 2.2× 261 6.6k
Vincenzo Barnaba 1.7k 1.1× 1.5k 1.0× 3.7k 3.0× 217 0.3× 1.2k 1.9× 148 6.5k
Lucy Golden‐Mason 1.4k 0.9× 1.5k 1.0× 2.5k 2.0× 321 0.4× 852 1.3× 88 4.5k
Hermann E. Wasmuth 2.3k 1.5× 2.3k 1.5× 941 0.8× 656 0.8× 701 1.1× 81 4.3k
Patrick Bertolino 1.2k 0.8× 1.2k 0.8× 2.9k 2.3× 760 1.0× 1.1k 1.7× 87 5.5k
Bertram Bengsch 1.1k 0.7× 872 0.6× 3.3k 2.7× 440 0.6× 749 1.1× 73 4.9k
Alessandra Franco 649 0.4× 458 0.3× 1.4k 1.1× 646 0.8× 635 1.0× 74 2.9k
I. R. Mackay 533 0.4× 349 0.2× 869 0.7× 403 0.5× 456 0.7× 88 2.9k
J. R. Batchelor 604 0.4× 311 0.2× 2.6k 2.1× 556 0.7× 465 0.7× 97 4.9k

Countries citing papers authored by Minoru Nakamura

Since Specialization
Citations

This map shows the geographic impact of Minoru Nakamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minoru Nakamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minoru Nakamura more than expected).

Fields of papers citing papers by Minoru Nakamura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minoru Nakamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minoru Nakamura. The network helps show where Minoru Nakamura may publish in the future.

Co-authorship network of co-authors of Minoru Nakamura

This figure shows the co-authorship network connecting the top 25 collaborators of Minoru Nakamura. A scholar is included among the top collaborators of Minoru Nakamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minoru Nakamura. Minoru Nakamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hitomi, Yuki & Minoru Nakamura. (2023). The Genetics of Primary Biliary Cholangitis: A GWAS and Post-GWAS Update. Genes. 14(2). 405–405. 13 indexed citations
3.
Hitomi, Yuki, Yoshihiro Aiba, Yosuke Kawai, et al.. (2021). rs1944919 on chromosome 11q23.1 and its effector genes COLCA1/COLCA2 confer susceptibility to primary biliary cholangitis. Scientific Reports. 11(1). 4557–4557. 8 indexed citations
4.
Bekki, Shigemune, Satoru Hashimoto, Kazumi Yamasaki, et al.. (2020). Serum kynurenine levels are a novel biomarker to predict the prognosis of patients with hepatocellular carcinoma. PLoS ONE. 15(10). e0241002–e0241002. 16 indexed citations
5.
Aiba, Yoshihiro, Kenichi Harada, Masahiro Ito, et al.. (2018). Increased expression and altered localization of cathepsin Z are associated with progression to jaundice stage in primary biliary cholangitis. Scientific Reports. 8(1). 11808–11808. 7 indexed citations
6.
Hitomi, Yuki, Kaname Kojima, Minae Kawashima, et al.. (2017). Identification of the functional variant driving ORMDL3 and GSDMB expression in human chromosome 17q12-21 in primary biliary cholangitis. Scientific Reports. 7(1). 2904–2904. 25 indexed citations
7.
Yasunami, Michio, Hitomi Nakamura, Katsushi Tokunaga, et al.. (2017). Principal contribution of HLA-DQ alleles, DQB1*06:04 and DQB1*03:01, to disease resistance against primary biliary cholangitis in a Japanese population. Scientific Reports. 7(1). 11093–11093. 26 indexed citations
8.
Shimoda, Shinji, Kenichi Harada, Yong Chong, et al.. (2015). Natural killer cells regulate T cell immune responses in primary biliary cirrhosis. Hepatology. 62(6). 1817–1827. 54 indexed citations
9.
Aiba, Yoshihiro, Keiko Yamazaki, Nao Nishida, et al.. (2015). Disease susceptibility genes shared by primary biliary cirrhosis and Crohn’s disease in the Japanese population. Journal of Human Genetics. 60(9). 525–531. 18 indexed citations
10.
Torigoshi, Takafumi, Tomohiro Koga, Yümi Maeda, et al.. (2012). Serum amyloid A (SAA) induces pentraxin 3 (PTX3) production in rheumatoid synoviocytes. Modern Rheumatology. 23(1). 28–35. 19 indexed citations
11.
Migita, Kiyoshi, Tomohiro Koga, Masahiro Izumi, et al.. (2012). Serum amyloid A triggers the mosodium urate -mediated mature interleukin-1β production from human synovial fibroblasts. Arthritis Research & Therapy. 14(3). R119–R119. 25 indexed citations
12.
Migita, Kiyoshi, Taiichiro Miyashita, Yasumori Izumi, et al.. (2011). Inhibitory effects of the JAK inhibitor CP690,550 on human CD4+ T lymphocyte cytokine production. BMC Immunology. 12(1). 51–51. 23 indexed citations
13.
Kawano, Akira, Shinji Shimoda, Takashi Kamihira, et al.. (2007). Peripheral Tolerance and the Qualitative Characteristics of Autoreactive T Cell Clones in Primary Biliary Cirrhosis. The Journal of Immunology. 179(5). 3315–3324. 11 indexed citations
14.
Kamihira, Takashi, Shinji Shimoda, Kenichi Harada, et al.. (2003). Distinct costimulation dependent and independent autoreactive T-cell clones in primary biliary cirrhosis. Gastroenterology. 125(5). 1379–1387. 48 indexed citations
15.
Okuma, Kazu, Minoru Nakamura, Shuji Nakano, Yoshiyuki Niho, & Yoshiharu Matsuura. (1999). Host Range of Human T-Cell Leukemia Virus Type I Analyzed by a Cell Fusion-Dependent Reporter Gene Activation Assay. Virology. 254(2). 235–244. 106 indexed citations
16.
Kira, Jun‐ichi, Kenji Yamasaki, Ichiro YAMAMOTO, et al.. (1997). Induction of Chronic Inflammatory Arthropathy and Mesenchymal Tumors in Rats Infected With HTLV-I. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 16(5). 380–392. 4 indexed citations
17.
Kitze, Bernd, Koichiro Usuku, Shuji Izumo, et al.. (1996). Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy. Journal of Neurology. 243(5). 393–400. 28 indexed citations
18.
Takahashi, Kazuhiro, et al.. (1992). Intravariceal tumor thrombi formation in hepatocellular carcinoma. A case report.. Kanzo. 33(11). 891–895. 1 indexed citations
19.
20.
Nakano, Shuji, Kenji Mitsugi, Keizo Anzai, et al.. (1992). In vivo comparative therapeutic study of optimal administration of 5-fluorouracil and cisplatin using a newly established HST-1 human squamous-carcinoma cell line. Cancer Chemotherapy and Pharmacology. 29(4). 273–276. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William M. Ridgway Breakdown of academic impact, for papers by K. H. Meyer zum Büschenfelde Breakdown of academic impact, for papers by Vincenzo Barnaba Breakdown of academic impact, for papers by Lucy Golden‐Mason Breakdown of academic impact, for papers by Hermann E. Wasmuth Breakdown of academic impact, for papers by Patrick Bertolino Breakdown of academic impact, for papers by Bertram Bengsch Breakdown of academic impact, for papers by Alessandra Franco Breakdown of academic impact, for papers by I. R. Mackay Breakdown of academic impact, for papers by J. R. Batchelor
Rankless by CCL
2026